Alain F.
- Country
- France
- Department
- Maladies Héréditaires du Métabolisme
Research Overview
Data & Insights
Has run more than one trial at 0 of 5 partner sites.
Specializations
Hereditary Metabolic Disorders
The investigator concentrates on inherited metabolic diseases that affect enzyme function and substrate processing, emphasizing disorders with unmet therapeutic needs.
- Late‑onset Pompe disease
- Glycogen storage disease type II
- Urea cycle disorders (UCD)
- Hereditary hypercholesterolemia
- Metabolic dysfunction‑associated steatohepatitis (MASH)
Research aims to translate novel metabolic modulators into clinical benefit for these rare conditions.
Advanced Solid Tumor Oncology
His work addresses therapeutic strategies for advanced solid malignancies, spanning common and rare tumor types across multiple organ systems.
- Non‑small cell lung cancer (NSCLC)
- Metastatic colorectal carcinoma
- Advanced hepatocellular carcinoma
- High‑grade serous ovarian cancer
- Rare sarcomas (e.g., synovial, rhabdomyosarcoma)
Efforts focus on molecularly targeted agents and immunotherapeutic combinations.
Hematologic Malignancies
He is actively involved in trials targeting hematologic cancers, with particular interest in high‑risk and refractory disease subsets.
- Acute myeloid leukemia (AML)
- Diffuse large B‑cell lymphoma (DLBCL)
- Multiple myeloma (MM)
- Chronic lymphocytic leukemia (CLL)
- Peripheral T‑cell lymphoma
Clinical programs explore novel kinase inhibitors, antibody‑drug conjugates, and cellular therapies.
Cardiovascular and Metabolic Risk
His portfolio includes studies on cardiovascular disease and metabolic syndrome, targeting prevention and disease modification.
- Atherosclerotic cardiovascular disease (ASCVD)
- Obesity and overweight
- Type 2 diabetes mellitus
- Hypertension
- Atrial fibrillation
Interventions range from lipid‑lowering biologics to anti‑inflammatory pathways.
Autoimmune and Inflammatory Disorders
He contributes to research on immune‑mediated diseases, focusing on conditions with chronic inflammation and organ involvement.
- Systemic lupus erythematosus (SLE)
- Inflammatory bowel disease (Crohn’s disease, ulcerative colitis)
- Vasculitis (ANCA‑associated)
- Atopic dermatitis
- Rheumatoid arthritis
Therapeutic exploration includes cytokine blockade and targeted small molecules.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.